Immune Deficiency
📧 Sign up to get email alerts when something new happens for Immune Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases [Phase 3]
Phase 3 trial evaluating pharmacokinetics, efficacy, tolerability, and safety of subcutaneous Newnorm immunoglobulin in patients with primar…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
This clinical trial update reports the completion of a study investigating the genetic basis of suppurative lung disease in children and adu…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults [Phase 2]
Phase 2 trial update for QBKPN Site-Specific Immunomodulator to improve innate immune function and reduce respiratory tract infections in ol…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16 [Phase 4]
Phase 4 clinical trial evaluating safety and pharmacokinetics of BIVIGAM in children with primary immune deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis [Phase 3]
Phase 3 trial update assessing CytoSorb hemoperfusion effects on immunoparalysis in sepsis; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Antibody Production in Immune Disorders [Phase 4]
Phase 4 clinical trial update for antibody production in immune disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig [Phase 2, Phase 3]
Clinical trial update for humoral immunodeficiency treated with rituximab and subcutaneous immunoglobulin in Phase 2 and Phase 3; study comp…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules [Phase 4]
Phase 4 study update evaluating weekly vs biweekly dosing of subcutaneous immunoglobulin IgPro20 (Hizentra) in patients with primary or seco…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Impact of Metabolic Syndrome on Flu Vaccine Efficacy [NA]
A terminated clinical trial investigating how metabolic syndrome affects flu vaccine efficacy, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Phase 3]
A Phase 3 Japan study evaluating subcutaneous immunoglobulin for patients with primary immune deficiency requiring IgG replacement therapy, …